OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Liver Disease is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Navigating the Management of Hepatocellular Carcinoma	427
Forthcoming Issues	78
Forthcoming Issues	46
Copyright	43
Special Population	43
Forthcoming Issues	39
Contributors	38
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease	38
Forthcoming Issues	34
Recurrent and De Novo Liver Disease After Liver Transplantation	31
Artificial Intelligence and Machine Learning Applications in Liver Disease	31
Primary Biliary Cholangitis	30
The Role of Liver Transplantation in Hepatocellular Carcinoma	24
Contents	24
Preface	23
Overview of New Targets for Hepatitis B Virus	23
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination	22
Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment	22
What is the Path Forward to Treat Hepatitis Delta Virus?	21
Pathogenesis of Alcohol-Associated Liver Disease	20
Consultations in Liver Disease	19
Preface	19
Nonalcoholic Fatty Liver Disease in Latin America and Australia	18
Evaluation and Management of Pruritus in Primary Biliary Cholangitis	17
The Diagnostic Pathway for Patients with Cholestatic Liver Disease	17

Portal Hypertension and its Complications	17
Primary Biliary Cholangitis	17
Copyright	16
Alcohol-Associated Liver Disease	16
Contributors	16
Substance Use Disorders and Interprofessional Management in the Pre and Post Liver Transplant Settings	15
Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America	14
Minimal Hepatic Encephalopathy	14
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia	14
Targeting Hepatitis B Virus DNA Using Designer Gene Editors	14
Primary Sclerosing Cholangitis	13
Recent Advances in Primary Biliary Cholangitis Treatment	13
Advances in Cholestatic Liver Disease	13
General Hepatology Concerns for the Patient with Cholestatic Liver Disease	13
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis	12
Biliary Atresia in Children	12
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease	12
Current and Next-Generation Therapeutics in Hepatology	11
Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats	11
Pharmacologic Management of Hepatic Encephalopathy	11
The Liver in Diabetes and Metabolic Syndrome	11
Copyright	11
Beyond the Liver	11
The Liver in Hematologic Malignancies	10
Treatment of Modifiable Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease	10
Novel Therapies in Primary Biliary Cholangitis	10
Treatment of Primary Sclerosing Cholangitis Including Transplantation	10
Hepatitis B and C in Children	10
Hepatocellular Carcinoma	10
Alcohol Use Disorder	10
Copyright	10
Prognostic Scoring Systems in Primary Biliary Cholangitis	10
Navigating Hepatocellular Carcinoma	9
Contents	9
Overview of Progressive Familial Intrahepatic Cholestasis	9
Acute Alcoholic Hepatitis	9
Preventing Readmissions for Hepatic Encephalopathy	9
Contents	9
Chronic Hepatitis B	9
Forthcoming Issues	9
Portal Hypertension and its Complications: A Guided Tour of the Post–Baveno 7 Landscape	8
Alcohol-Related Liver Disease	8
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?	8
Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean	8
Alagille Syndrome	8
Primary Biliary Cholangitis	8
Disparities in Alcohol-Related Liver Disease	8
Hepatic Encephalopathy	8
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis	8
Genetics of Primary Biliary Cholangitis	8

Renal Insufficiency in Patients with Cirrhosis	8
Contents	8
Disease Modulating Agents in Cirrhosis	8
Amyloidosis and the Liver	8
State of the Art	8
Systemic Complications of Primary Biliary Cholangitis	7
Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis	7
Chronic Hepatitis B Virus and Hepatitis D Virus	7
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis	7
Genetic Cholestasis Syndromes	7
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease	7
Hepatic Encephalopathy in Acute-on-Chronic Liver Failure	7
Contributors	7